PaperSingle dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen
References (35)
- et al.
Controlled release vaccinesbiodegradable polylactide/polyglycolide () microspheres as antigen vehicles
Immunobiology
(1992) - et al.
Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations
Vaccine
(1995) - et al.
Long term antibody responses in mice following subcutaneous immunisation with ovalbumin entrapped in biodegradable microparticles
Vaccine
(1993) - et al.
Biodegradable delivery system for single step immunisatuion with tetanus toxoid
Int. J. Pharm.
(1993) - et al.
Immunogenicity studies on diptheria toxoid loaded biodegradable microspheres
Int. J. Pharm.
(1992) - et al.
Biodegradable microspheres as a vaccine delivery system
Molec. Immun.
(1991) - et al.
Resorbable synthetic polymers as replacements for bone graft
Clin. Mater.
(1994) - et al.
Two-ply biodegradable nerve guide: basic aspects of design, construction and biological performance
Biomaterials
(1990) Use of vicryl (polyglactin 910) sutures in general surgical and cardiothoracic procedures
Am. J. Surg.
(1977)- et al.
The preparation and characterisation of poly(lactide co-glycolide) microparticles. 3. Microparticle/polymer degradation rates and the in vitro release of a model protein
Int. J. Pharm.
(1994)
Measurement of protein using bicinchoninic acid
Analyt. Biochem.
(1985)
Polymers for the sustained release of macromolecules. Their use in a single step method of immunisation
Meth. Enzym.
(1981)
Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(DL lactic acid co-glycolic acid) microspheres
J. Contr. Rel.
(1995)
The influence of biodegradable microcapsule formulations on the controlled release of a protein
J. Contr. Release
(1994)
Adjuvant activity of non-ionic block copolymers. IV Effect of molecular weight and formulation on titre and isotype of antibody
Vaccine
(1991)
Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants
Vaccine
(1988)
dose and load studies for subcutaneous and oral delivery of poly(lactide co-glycolide) microspheres containing ovalbumin
Pharm. Res.
(1994)
Cited by (82)
Poly(lactic acid)-based particulate systems are promising tools for immune modulation
2017, Acta BiomaterialiaImmune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles
2016, International Journal of PharmaceuticsBiodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens
2015, European Journal of PharmacologyActive self-healing encapsulation of vaccine antigens in PLGA microspheres
2013, Journal of Controlled Release
- †
Present address: Proteus Molecular Design, Lyme Green Business Park, Macclesfield, UK.
Copyright © 1996 Published by Elsevier Ltd.